Close

Biogen (BIIB) PT Raised to $341 at RBC Capital following neurologist survey on donamenab Jul 11, 2023 06:41AM
RBC Capital on Biogen (BIIB): 'CMS Makes It Clear - Leqembi Will Be Broadly Reimbursed - Should Reduce Overhang' Apr 26, 2023 03:16PM
RBC Capital on Biogen (BIIB): 'FDA Summary Review Now Available; We Believe Suggests High Amenability For Future Full Leca Approval' Jan 10, 2023 09:50AM
Biogen (BIIB) gains ahead of lecanemab PDUFA Jan 6, 2023 07:05AM
RBC Capital on Biogen (BIIB): 'a very favorable stock setup' Jan 5, 2023 04:11PM
View Older Stories

Nov 28, 2022 10:05AM Biogen (BIIB) Stock Falls on Alzheimer's Drug Trial Death Reports
May 3, 2022 07:21AM Biogen CEO to step down; drugmaker pulls back on Alzheimer's drug Aduhelm
Mar 3, 2022 05:16AM RBC Capital Upgrades Biogen (BIIB) to Outperform
Jan 13, 2022 10:55AM Biogen (BIIB) Gains as CEO Hints at 'Strategic Options'
Nov 17, 2021 07:45AM Biogen's Alzheimer's drug gets negative European panel vote
Oct 7, 2021 06:11AM Ionis Pharmaceuticals (IONS) is High Risk but RBC Capital Likes the Setup Into ALS Data
Sep 22, 2021 07:07AM Biogen (BIIB) Analyst Day Offered Little Incremental Value - RBC Capital
Jun 28, 2021 05:45AM UPDATE: Biogen (BIIB) PT Lowered to $354 at RBC Capital
Jun 10, 2021 05:11PM Prothena Corp (PRTA) PT Raised to $50 at RBC Capital
Dec 1, 2020 06:58AM UPDATE: Biogen (BIIB) PT Raised to $256 at RBC Capital After SAGE Deal Call
Oct 19, 2020 06:45AM Biogen (BIIB) PT Lowered to $268 at RBC Capital After Mock Adcomm
Sep 18, 2020 11:49AM Biogen's (BIIB) Tecfidera Drop-off Will Be Larger than Expected, PT Lowered to $277 - RBC Capital
Jun 18, 2020 09:49AM Biogen (BIIB) Tecfidera Reduction Impact ~$20/Share - RBC
Jun 18, 2020 09:26AM Pre-Open Stock Movers 06/18: (ALPN) (AEMD) (ELOX) Higher; (LPTX) (QUIK) (BIIB) Lower (more...)
May 29, 2020 07:07AM Biogen (BIIB) PT Lowered to $303 at RBC Capital Ahead of District Court Rulings
Feb 5, 2020 03:26PM Biogen (BIIB) PT Raised to $321 at RBC Capital
Jan 30, 2020 01:09PM Biogen (BIIB) PT Lowered to $280 at RBC Capital
Jan 28, 2020 07:07AM RBC Capital Remains on Biogen (BIIB) Sidelines Ahead of PTAB IPR Decision
Nov 18, 2019 12:49PM Biogen (BIIB) New 'Mystery' Candidate BIIB101 Moves Into Clinic - RBC
Oct 22, 2019 05:08PM Biogen, Eisai revive plans for Alzheimer's drug, surprising market
Oct 22, 2019 07:32AM Biogen (BIIB) News 'Somewhat Astonishing', Shares Could Trade Back Toward Low-$300s - RBC
Sep 16, 2019 01:51PM Biogen (BIIB) BG00011 Just Stopped For Toxicity, But Low Impact - RBC
Sep 6, 2019 07:31AM Biogen (BIIB) Competitor Likely to Post Pivotal Results Next Week - RBC Capital
Jul 24, 2019 06:44AM Biogen (BIIB) PT Raised to $242 at RBC Capital
Apr 25, 2019 06:38AM Biogen (BIIB) PT Lowered to $234 at RBC Capital
Mar 25, 2019 07:12AM Biogen (BIIB) PT Slashed At RBC On Alzheimer's Prospects
Feb 12, 2019 06:48AM Complex Setup Keeps RBC on Sidelines with Biogen (BIIB); PT Lowered to $318
Jan 30, 2019 06:25AM Biogen (BIIB) PT Lowered to $337 at RBC Capital
Jan 3, 2019 03:59PM Bristol-Myers/Celgene Deal Likely Kicks Off 'Big Year' In Biopharma M&A - RBC
Nov 26, 2018 07:03AM Biogen (BIIB) PT Lowered to $338 at RBC Capital on Underappreciated Tecfidera IP Risk
Oct 24, 2018 06:55AM Biogen (BIIB) PT Raised to $364 at RBC Capital
Jul 25, 2018 07:44AM Biogen (BIIB) PT Raised to $357 at RBC Capital
Jul 6, 2018 06:59AM Biogen (BIIB): Positive Alzheimer's Data Likely A Big Catalyst - RBC
May 31, 2018 03:56PM RBC Positive on Biogen (BIIB) Karp Hire Amid Partnerships/M&A Potential
May 31, 2018 01:42PM RBC Sees Positive Read-Through to Alder Biopharm (ALDR) from Allergan, Biogen Developments
May 15, 2018 07:56AM Vertex Pharma (VRTX), Alexion Pharma (ALXN) Least Impacted from Trump Drug Policies - RBC
Apr 25, 2018 07:43AM Biogen (BIIB) PT Lowered to $311 at RBC Capital
Apr 18, 2018 01:59PM Biogen (BIIB) Missed Out on AveXis (AVXS) But Well-Positioned for Substantial Acquisition - RBC
Jan 25, 2018 09:30AM Pre-Open Movers 01/25: (DLB) (VAR) (MKC) Higher; (CFMS) (OCUL) (NWL) Lower (more...)
Sep 15, 2017 02:20AM RBC Capital Starts Biogen (BIIB) at Sector Perform
Feb 15, 2017 05:29PM Biogen to Present at the 2017 RBC Capital Markets Global Healthcare Conference
Dec 6, 2016 07:05AM Trump's corporate tax holiday could spur pharma M&A
Sep 28, 2016 09:10AM Pre-Open Stock Movers 09/28: (SEED) (AVXL) (ATHX) Higher; (GALT) (TPX) (SONC) Lower (more...)
Sep 20, 2016 10:32AM Allergan pays top dollar for 'stepping stones' from neurology to dermatology
Sep 16, 2016 04:52PM Perrigo explores sale of royalties of drug Tysabri: sources
Aug 2, 2016 03:41PM Biogen (BIIB) Could Be Worth $375-475/Share in a Takeover - RBC Capital's Yee
Jul 28, 2016 01:53PM U.S. biotech stocks win back investors in big July run
Jun 29, 2016 10:23AM Notable Analyst Rating Changes 6/29: (DYN) (CNC) (DAR) Upgraded; (HAR) (ESPR) (ZION) Downgraded
Apr 4, 2016 01:52PM Biotech Seen Grinding Higher, Says RBC Capital (IBB)
Oct 21, 2015 09:22AM RBC Comments on Bull/Bear Case on Biogen (BIIB) Following Q3 Results
View Older Stories